XClose

UCL Innovation and Enterprise

Home
Menu

Archive of News

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>

28 May 2014: Blood vessel research offers insights into new treatments for eye diseases

Leukaemia drugs could help to improve treatments for blindness caused by abnormal blood vessel growth in the eye, finds new UCL research. More...

21 May 2014: UCL, Imperial & Cell Therapy Catapult collaborate to advance leukaemia cell therapy

A novel cell therapy approach to the treatment of acute myeloid leukaemia is to be developed further via an innovative partnership between the Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, UCL Business (UCLB) and Imperial Innovations. More...

14 May 2014: Novozymes Biopharma to offer drug-albumin conjugation platform in collaboration with UCLB spinout ThioLogics

ThioLogics, a UCL Business company, spun-out of the UCL Department of Chemistry has entered into a new collaboration with Novozymes Biopharma.
More...

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>